Forma Therapeutics Holdings, Inc.
FMTXDelisted Oct 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001538927
Forma Therapeutics Holdings, Inc. was delisted on Oct 14, 2022; its insiders filed their last Form 4 on Oct 14, 2022; 139 institutions reported holding it in 13F filings for Q3 2022, worth $835.0M in total; HHLR Advisors (Hillhouse) was the only superinvestor holding it.
Holders of 5% or more of FMTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Forma Therapeutics Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Forma Therapeutics Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Forma Therapeutics Holdings, Inc., newest first.
No Schedule 13D or 13G filings on Forma Therapeutics Holdings, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Forma Therapeutics Holdings, Inc. shares.
No Form 144 notices for Forma Therapeutics Holdings, Inc. are on file.